Shandong Pharmaceutical Glass Co.Ltd

600529

CNE000001BG9

Non-Paper Containers & Packaging

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
31.66 ^CNY	-0.41%		+1.31%	+23.67%

2023	Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Shandong Pharmaceutical Glass Co., Ltd(SHSE:600529) added to Shanghai Stock Exchange Health Care Sector Index

December 13, 2021 at 12:00 am EST

Shandong Pharmaceutical Glass Co., Ltd has been added to Shanghai Stock Exchange Health Care Sector Index .

Latest news about Shandong Pharmaceutical Glass Co.Ltd

Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-18	CI
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Shandong Pharmaceutical Glass Co., Ltd announced that it has received CNY 1.866494692 billion in funding	22-11-28	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Triumph Science & Technology Co.,Ltd cancelled the acquisition of a 11% stake in Shandong Pharmaceutical Glass Co., Ltd from Shandong Luzhong Investment Co., Ltd.	22-07-19	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-25	CI
Shandong Pharmaceutical Glass Co., Ltd(SHSE:600529) added to Shanghai Stock Exchange Health Care Sector Index	21-12-13	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI
Shandong Pharmaceutical Glass Co., Ltd announced that it expects to receive CNY 1.8664947 billion in funding	21-09-06	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-23	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-04-26	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-19	CI
Shandong Pharmaceutical Glass Co., Ltd(XSSC:600529) added to FTSE All-World Index	20-09-21	CI
Shandong Pharmaceutical Glass Co., Ltd(XSSC:600529) added to S&P Global BMI Index	20-09-21	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-17	CI
Shandong Pharmaceutical Glass Co., Ltd Announces Cash Dividend for the Year 2019, Payable on July 7, 2020	20-06-29	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-27	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-27	CI
Shandong Luzhong Investment Co., Ltd. completed the acquisition of 15.7% stake in Shandong Pharmaceutical Glass Co., Ltd from YiYuan State-owned Assets Administration Committee.	19-11-18	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-21	CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-19	CI

Chart Shandong Pharmaceutical Glass Co.Ltd

Duration

Period

Chart Shandong Pharmaceutical Glass Co.Ltd

More charts

SHANDONG PHARMACEUTICAL GLASS CO., LTD is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical glass products. The Company's products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops and others. The Company distributes its products in domestic and overseas markets.

Sector

Non-Paper Containers & Packaging

Calendar

2024-04-22 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Shandong Pharmaceutical Glass Co.Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

31.66 CNY

Average target price

34.47 CNY

Spread / Average Target

+8.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glass Containers & Packaging

	1st Jan change	Capi.
SHANDONG PHARMACEUTICAL GLASS CO.LTD	+23.67%	2.91B
VERALLIA	-0.29%	4.33B
VIDRALA, S.A.	+2.45%	3.29B
ZIGNAGO VETRO S.P.A.	-14.03%	1.16B
VETROPACK HOLDING AG	-19.18%	679M
ANADOLU CAM SANAYII A.S.	0.00%	598M
THE NATIONAL COMPANY FOR GLASS INDUSTRIES	+15.38%	405M
CHONGQING ZHENGCHUAN PHARMACEUTICAL PACKAGING CO.,LTD	-31.56%	289M
ANHUI DELI HOUSEHOLD GLASS CO., LTD.	-39.58%	221M
CRISTALERÍAS DE CHILE S.A.	-1.93%	187M

Glass Containers & Packaging